Scientists test re-engineered immune cells to fight untreatable MS
Disease control
Ongoing
This is an early-phase study testing a new personalized cell therapy called KYV-101 in 10 people with progressive multiple sclerosis (MS) that hasn't improved with standard treatments. Researchers will collect a patient's own immune cells, modify them in a lab to target B cells t…
Phase: PHASE1 • Sponsor: Bruce Cree • Aim: Disease control
Last updated Apr 02, 2026 07:42 UTC